Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peng Yin
Harvard Medical School, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ultivue
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Yin is an inventor of single-molecule super-resolution imaging technology referred to as DNA-PAINT which is subject to a license agreement between Harvard and Ultivue Inc. Ultivue is based on DNA-PAINT and DNA-Exchange technologies. Dr. Yin holds equity in the company and he has an agreement to receive compensation for consulting services. The research project’s goals include establishing a Characterization Unit to perform and integrate single-cell genomics, multiplex flow cytometry and highplex imaging using two methods reduced to practice within the Center: tissue-based cyclic immunofluorescence (t-CyCIF) and DNA exchange imaging (DEI).
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center)
NARRATIVE Construction of Pre-Cancer Atlases comprising detailed spatial and molecular data on cell state and omic data in melanoma and clonal hematopoiesis will join together the two primary means of diagnosing human cancer: histology and genetics. The atlases we construct will help to identify patients with pre-cancer skin lesions and blood conditions at risk of progressing to malignancy at a sufficiently early stage that aggressive disease can be prevented.
Filed on October 01, 2018.
Tell us what you know about Peng Yin's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Peng Yin”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Peng Yin | Harvard Medical School | Conflict of Interest | Ultivue, Inc. | Value cannot be readily determined |
| Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | $0 - $4,999 |
| Peng Yin | Harvard Medical School | Conflict of Interest | Ultivue, Inc. | $100,000 - $149,999 |
| Peng Yin | Harvard Medical School | Conflict of Interest | Ultivue, Inc. | $100,000 - $149,999 |
| Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | Value cannot be readily determined |
| Peng Yin | Harvard Medical School | Conflict of Interest | Ultivue, Inc. | Value cannot be readily determined |
| Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | $100,000 - $149,999 |
| Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | $100,000 - $149,999 |
| Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.